Apr 24, 2017
Envision announces Altmetric attention data now available in Library™ scientific content management software
Glastonbury, USA, April 24, 2017 – Envision Pharma Group (‘Envision’), a leading Medical Affairs-focused scientific communications and technology solutions provider, announced today that Library – Envision’s searchable content management system for Medical Affairs materials, including publications and multimedia – will now feature attention data provided by data science company Altmetric.
The ‘impact’ of a peer-reviewed publication is an integral part of the assessment of the effectiveness of an individual publication or cumulatively, of a publication plan. While citations have long been considered the standard measure of publication impact, they may on occasions take months or years to emerge. The shift to an online publication environment and the rise of social media have allowed the real-time assessment of indicators of dissemination (eg, via Twitter), interest (eg, news coverage), and readership (eg, Mendeley). Envision has partnered with Altmetric, the leading provider of such metrics, to facilitate access to these informative data via the Library content management solution – part of the expanding iEnvision suite of medical project management software solutions.
Fully integrated into the publication details held within Library, Altmetric badges and associated attention scores provide constantly updated, at-a-glance indicators of the engagement relating to published articles, and permit click-through-access to the Altmetric.com website for more detailed information on the demographic, geographic, and contextual nature of these data please see Altmetric links below.
Library is built on the iEnvision™ Medical Project Management platform, purpose-built to meet the needs of Medical Affairs and related functions. Library can be fully integrated with current versions of Datavision® (publications management), as well as other third-party and corporate applications.
Russell Traynor, Envision’s Platform Director for iEnvision and former chair of the International Society of Medical Publication Professionals noted: “We are excited to announce this collaboration and hope that the addition of Altmetric data to Library will provide additional insights and value to the users of our solutions.”
Catherine Williams, Chief Marketing Officer, of Altmetric commented: “We’re really pleased to see Envision integrating our data and badges into the Library platform. The attention insights provided will be useful for pharmaceutical companies and communications agencies in assessing the performance of their own publications as well as those of their competitors, and will be a powerful tool for more informed strategic planning.”
Founded in 2001, Envision Pharma Group is a global, innovative technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies.
Envision is a leading provider of evidence communication services and industry-leading, technology solutions that have applicability across areas of Medical Affairs responsibility.
Under consistent leadership, Envision has grown steadily across its three core business areas in support of Medical Affairs:
Evidence Communication—including strategic publication planning, data dissemination services, medical education, and Market Access communications;
Technology Solutions—design, development, implementation, and support of innovative and strategic management software, purpose-built for life-science clients, including: publication planning and management (Datavision®), clearance and approval (Clear®), activity request and evidence generation management (Visiontracker®), workflow management for Health Economics and Outcomes Research activities (Visiontracker HEOR™), workflow management for Early Access Program activities (Visiontracker EAP™), searchable repository for the appropriate sharing of scientific content (Library™), and a next-generation solution for managing medical information enquiries (Medinfo™); and;
Operational Excellence—policy, process, and compliance support and consultancy for Medical Affairs.
Envision has twelve offices: four in the United Kingdom – Horsham, Wilmslow, Marlow, and London; six in the United States – Philadelphia, PA, Southport, CT, Madison, NJ, Stirling, NJ, Glastonbury, CT, and New York, NY; and two in the Asia-Pacific region – Tokyo and Sydney. The company employs 550 team members, including more than 200 highly qualified and experienced in-house medical writers and more than 100 technology solutions team members who provide software development and customer support. Envision provides services and technology solutions to more than 75 companies, including 19 of the top 20 pharmaceutical companies.
Altmetric was founded in 2011 and has made it a mission to track and analyze the online activity around scholarly literature. It collates what people are saying about published research outputs in sources such as the mainstream media, policy documents, social networks, blogs, and other scholarly and non-scholarly forums to provide a more robust picture of the influence and reach of scholarly work. Altmetric works with some of the biggest publishers, funders, and institutions around the world to deliver this data in an accessible and reliable format.
Altmetric is supported by Digital Science – a technology company that combines world-class technology with a resolute focus on scientists and those who support the research process. Find out more at altmetric.com and follow us on Twitter @altmetric.
Digital Science is a technology company serving the needs of scientific and research communities, at the laboratory bench or in a research setting. It invests in and incubates scientific software companies that simplify the research cycle, making more time for discovery. Its portfolio companies and investments include a host of leading and admired brands including Altmetric, BioRAFT, Figshare, GRID, Labguru, Peerwith, Overleaf, ReadCube, Symplectic, TetraScience, Transcriptic, and ÜberResearch. It is operated by global media company, the Holtzbrinck Publishing Group. Visit http://www.digital-science.com and follow @digitalsci on Twitter.